Introduction

Changes in extracellular Ca
2+ concentrations, as are seen in normal unperturbed epidermis or after epidermal permeability perturbation, control epidermal functions such as differentiation, barrier repair, keratinocyte cell-to-cell adhesion and keratinocyte motility (Fang et al., 1998; Mao-Qiang et al., 1997; Vasioukhin et al., 2000) . Thus, transducing changes in extracellular Ca 2+ levels into intracellular Ca 2+ signals that control these processes is essential for keratinocyte and epidermal viability.
Increasing extracellular Ca 2+ concentration in cultured keratinocytes mimics many of the changes in keratinocyte differentiation and cell-to-cell adhesion seen in vivo (Pillai et al., 1990; Stanley and Yuspa, 1983; Vasioukhin et al., 2000) , through a well-defined pathway that uses a plasma-membranebound Ca 2+ receptor (CaR) to signal intracellular Ca 2+ release, and subsequent long-lasting Ca 2+ influx (Fatherazi et al., 2003; Oda et al., 1998) . The coordinated responses to raised extracellular Ca 2+ levels establish a new resting cytosolic concentration that continues to increase slowly (days to weeks) as the cells are exposed to continuing high levels of extracellular Ca 2+ (Pillai et al., 1990) . Initial studies found that emptying the endoplasmic reticulum (ER) Ca 2+ store by pharmacologically inhibiting the Ca 2+ -ATPase, SERCA2, responsible for sequestering Ca 2+ , impaired the cells' response to raised extracellular Ca 2+ (Li et al., 1995) . These studies suggested that keratinocytes, like most other non-excitable cells, used only the ER Ca 2+ store. However, more recent studies have demonstrated that the Golgi Ca 2+ store, sequestered by a related Ca 2+ -ATPase, hSPCA1, also is required for Ca 2+ signaling in response to raised extracellular Ca 2+ concentrations. Mutations in the Golgi hSPCA1 cause another inherited skin disorder, Hailey-Hailey disease (HHD). Keratinocytes from HHD patients do not respond to raised extracellular Ca 2+ levels and suffer from depleted Golgi Ca 2+ stores, even though ER Ca 2+ stores are normal (Hu et al., 2000) . Further, experimental manipulation of the hSPCA1 demonstrates that keratinocytes, but not COS cells, require the hSPCA1-mediated Golgi Ca 2+ store for normal signaling (Callewaert et al., 2003 is mutated (Sakuntabhai et al., 1999) . Like HHD, this disease is characterized by impaired differentiation and abnormal cell-to-cell adhesion. Keratinocytes with these naturally occurring mutations allow us to determine how keratinocytes adapt to impaired ER Ca 2+ stores, and also to examine the relative contributions of ER vs Golgi Ca 2+ stores in the Ca 2+ -signaling cascade in response to raised extracellular Ca 2+ levels.
Three isoforms of SERCA2 are generated by alternative splicing of exon 20 and exon 21. Isoform 'a' is the cardiac sarco-endoplasmic Ca 2+ pump whereas isoform 'b' is the major SERCA isoform in non-muscle cells, including epidermal cells (Wuytack et al., 1989; Wuytack et al., 2002) . SERCA2c, a recently described splice variant, is expressed in epithelial, mesenchymal and hematopoietic cell lines, and in monocytes (Gelebart et al., 2003) . SERCA2b contains an additional transmembrane domain, which places the Cterminus of the protein in the lumen of the ER, whereas this terminus is cytosolic in SERCA2a. Both the SERCA2a and SERCA2b isoforms are highly expressed in cultured keratinocytes but only SERCA2b is found in the epidermis. Loss of the SERCA2b isoform is sufficient to cause DD . SERCA2 sequesters Ca 2+ in the ER whereas hSPCA1 localizes to the trans-Golgi membrane and sequesters Ca 2+ in the Golgi (Behne et al., 2003) . hSPCA1 transports Ca 2+ with an affinity comparable to that of the ER SERCA2b pump (Lytton et al., 1992; Ton et al., 2002) . hSPCA1 also transports Mn 2+ ions with high affinity (Fairclough et al., 2003; Ton et al., 2002) . hSPCA1 is responsible for 67% of the Ca 2+ uptake into the Golgi (Callewaert et al., 2003) , which is consistent with the observation that ATP2C1 transcripts are highly expressed in keratinocytes (Hu et al., 2000) .
In this report, we show that DD keratinocytes overexpress hSPCA1 in compensation for decreased SERCA2, and thereby retain a near-normal response to raised extracellular Ca
2+
concentrations. These studies demonstrate that the Golgi Ca 2+ -ATPase hSPCA1 mediates a compensatory mechanism for the functional deficiency in the ER Ca 2+ -ATPase seen in DD keratinocytes and confirm that keratinocytes use the hSPCA1-controlled Golgi Ca 2+ store to mediate Ca 2+ signaling.
Results
SERCA2 mutations decrease SERCA2 protein levels and deplete SERCA2-controlled and total cellular Ca 2+ stores We first confirmed that SERCA2 protein was decreased in the DD keratinocytes (Fig. 1) . Preliminary studies demonstrated that ATP2A2 mRNA synthesis was tightly grouped among keratinocytes taken from four unrelated adult donors (data not shown); thus keratinocytes from one normal adult were used as controls in the following experiments. The S920Y (DD2) and N767S (DD5) mutations led to a minor decrease (about 25%) in the amount of total endogenous SERCA2 protein (WT + mutated protein), whereas mutations Y203del (DD1), A998fsX33 (DD3) and S346F (DD4) caused a more profound decrease (up to 50%). These results are consistent with previous functional analysis of the S920Y and A998fsX33 mutations using overexpression of a mutated cDNA (Ahn et al., 2003; Dhitavat et al., 2003; Dode et al., 2003 (Csernoch et al., 2000; Fatherazi et al., 2003 to a final concentration of 0.06 mM (the same concentration in which the cells were grown), which does not significantly activate the keratinocyte plasma membrane CaR (Oda et al., 1998) . When extracellular Ca 2+ was restored after emptying Ca 2+ stores, we found that capacitive Ca 2+ entry was larger in DD relative to normal keratinocytes, consistent with diminished ER stores and normal signaling between intracellular Ca 2+ stores and plasma membrane channels (Table 4 , Fig. 3 ). Unlike pancreatic cells containing mutated 
Fig. 2. The Ca
2+ response is preserved in DD keratinocytes. Normal and DD keratinocytes were cultured on glass coverslips in medium containing 0.06 mM Ca 2+ until they were ~50% confluent, then loaded with the Ca 2+ -sensitive dye Fura-2 (see Materials and Methods). The cells initially were superfused with control solution containing: 138 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 1.0 mM Na 2 HPO 4 , 0.06 mM CaCl 2 ; 10 mM glucose, pH 7.4, 286 mOsm, then switched to this solution with 1.0 mM Ca 2+ added (arrow). Although the baseline Ca 2+ concentrations were much lower in DD keratinocytes, both normal and DD keratinocytes responded with a sustained increase in intracellular Ca 2+ after exposure to raised extracellular Ca 2+ levels. The absolute increase in intracellular Ca
2+
was similar between DD and control keratinocytes, whereas the fold increase was significantly higher in DD keratinocytes (see Table 2 ). (Behne et al., 2003; Hu et al., 2000) . Because hSPCA1 constitutes the second major mechanism for sequestering intracellular Ca 2+ in keratinocytes, we next investigated whether decreases in SERCA2 stimulated a compensatory upregulation of hSPCA1. We found that hSPCA1 was markedly upregulated in all DD keratinocytes studied (Fig. 4) . These data, combined with the functional signaling characteristics of DD keratinocytes, suggested that hSPCA1 upregulation might compensate for SERCA2 dysfunction.
Plasma membrane Ca 2+ -ATPases (PMCA) also are known to regulate Ca 2+ extrusion. However, of the five DD patients studied, only two, DD2 (S920Y) and DD3 (A998fsX33), overexpressed total PMCA or PMCA-4. The others displayed a normal (DD4, S346F; DD5, N767S) or slightly decreased (DD1, Y203del) level of PMCA, indicating that PMCA expression was variable among DD patients. These data, coupled with the functional Ca 2+ efflux data above, suggest that changes in hSPCA1, but not PMCA or PMCA-4, underlie the compensatory changes in DD keratinocytes that allow normal Ca 2+ signaling in response to raised extracellular Ca (Behne et al., 2003; Hu et al., 2000) . To test whether compensatory hSPCA1 upregulation enables DD keratinocytes to respond to extracellular Ca 2+ levels, even in the face of SERCA2 dysfunction, we inactivated ATP2C1 in DD keratinocytes using small interfering RNA (siRNA). RNA interference (RNAi) is a strategy whereby genes are silenced post-translationally by treatment with sequence-specific double-stranded RNA. Cellular exposure to siRNA results in the selective degradation of the complementary native RNA (McManus and Sharp, 2002) . Our siRNA oligonucleotides were designed to avoid any overlap between ATP2C1 and ATP2A2 (confirmed by BLAST analysis). To assess nonspecific effects, we measured ATP2A2 cDNA expression after treatment with ATP2C1 siRNA. Only a 10% reduction in ATP2A2 cDNA was observed after treatment with ATP2C1 siRNA in normal keratinocytes, confirming that any changes in Ca 2+ signaling were due specifically to decreases in hSPCA1. Normal and DD human keratinocytes were cultured in six-well plates to 75% confluence, then treated with siRNA (8 g/well). Control samples were treated with transfection reagent and annealing buffer only. In preliminary experiments, we found that siRNA decreased ATP2C1 mRNA by approximately 80% within 24 hours after treatment.
Since a drop in protein levels generally lags behind a decrease in mRNA, we next assessed protein levels and compared these with changes in Ca 2+ signaling in normal and DD keratinocytes treated with siRNA to ATP2C1. Normal keratinocytes treated with siRNA displayed normal Ca 2+ signaling, confirmed by measuring normal hSPCA1 protein levels, 48 hours after siRNA treatment (data not shown). By 72 hours, however, hSPCA1 protein levels dropped, and Ca 2+ signaling in normal keratinocytes correspondingly changed to resemble the abnormal Ca 2+ signaling seen in Hailey-Hailey keratinocytes, in which the hSPCA1 is mutated (Hu et al., 2000) . Specifically, baseline cytosolic Ca 2+ concentrations increased, and the ability to respond to raised extracellular Ca 2+ levels diminished, after exposure to siRNA (Fig. 5 and Table  6 ). DD keratinocytes responded more quickly to siRNA, demonstrating decreased hSPCA1 levels and abnormal Ca 2+ -signaling parameters within 48 hours of siRNA treatment. Resting Ca 2+ concentrations, although increased, did not reach cytosolic Ca 2+ levels seen in normal keratinocytes, demonstrating that Ca 2+ signaling changes at 48 hours were due to selective inhibition of hSPCA1 synthesis and not nonspecific toxicity. In contrast to normal keratinocytes, DD keratinocytes became pyknotic and did not cleave the Fura-2 dye to its active form at 72 hours, demonstrating that these cells were no longer viable. In both normal and DD keratinocytes, transfection-reagent-treated control cells did not differ from untreated keratinocytes (compare Table 6 to Table 3 ). These data confirm that hSPCA1 is essential for Ca responses. Further, these data suggest that increased hSPCA1 compensation for dysfunctional SERCA2 is essential for DD Total protein extracts were analyzed by immunoblotting using specific antibodies to PMCA1 and PMCA4 and hSPCA1. Internal controls were GAPDH or ␤-actin. The OD values result from the densitometric analysis of the bands. These data are representative of two separate experiments. Inactivating ATP2C1 with siRNA blocks the Ca 2+ response in DD keratinocytes. DD keratinocytes were cultured on glass coverslips until ~40% confluent, then treated with ATP2C1 siRNA (see Materials and Methods). Forty-eight hours after treatment, at 50% confluence, cells were loaded with Fura-2 and intracellular Ca 2+ was measured by the protocol detailed in Fig. 2 . Ca 2+ in the superfusing fluid was raised from 0.06 to 1.0 mM (black arrow). The Ca 2+ response was blunted in DD keratinocytes treated with siRNA to ATP2C1 (top), whereas control DD keratinocytes responded normally to raised extracellular Ca 2+ (bottom). The P value ( is decreased in DD keratinocytes (Tables 2 and 4) , it is likely that Ca 2+ release from this compartment in response to raised extracellular Ca 2+ is decreased in DD cells. As the hSPCA1 is upregulated in these DD keratinocytes, it appears that increased Ca 2+ signaling via the Golgi Ca 2+ store compensates for defective SERCA2-dependent signaling. The proposed changes in Ca 2+ signaling pathways in DD vs normal keratinocytes are described in Fig. 6 .
To date, 22 mutations of the ATP2A2 gene have been studied by site-directed mutagenesis of the ATP2A2 cDNA and overexpression in COS-1 or HEK293 cells (Ahn et al., 2003; Dode et al., 2003; Sato et al., 2004) . Nonsense (Q790X, E917X) and frame-shift (1625delAG) mutations studied resulted in truncated pump proteins that were susceptible to degradation by the proteasome (Ahn et al., 2003) . Most DD mutants (10 out of 12) displayed decreased expression and/or stability with the exception of two mutants (C344Y and V843F) (Ahn et al., 2003) . Kinetic analyses of SERCA2 missense variants revealed that any one of the SERCA2 catalytic cycle steps (Ca 2+ binding, autophosphorylation from ATP, conformational change, release of bound Ca 2+ into the ER lumen and dephosphorylation) could be affected. Depending on the location of the amino acid substitution, the activity of the mutated pump may be decreased (most of the missense mutations), increased (S920Y), or abolished when the phosphorylation step is affected (T357K, G769R) Sato et al., 2004) . Furthermore, some missense mutants (N39D, N39T, C344Y, F487S, S920Y) inhibit the activity of native and recombinant wild-type SERCA2b by directly interacting with the wild-type pump (Ahn et al., 2003) . Patient DD2 in this work bears the S920Y mutation studied by others (Ahn et al., 2003; Dode et al., 2003) . Our results show that the resting cytosolic Ca 2+ concentration in these cells was lower than that of the control but higher than in the four other DD cells studied. The kinetic analyses by Dode et al. revealed (Ahn et al., 2003) . This could explain the intermediate level of resting Ca 2+ concentrations in DD2 cells. All these results demonstrate that DD is caused in most cases by haploinsufficiency of SERCA2b, which could be amplified when the mutated pump has a dominant-negative effect. The analysis of L321F (Sato et al., 2004) revealed that a decreased Ca 2+ affinity and insensitivity to the feedback inhibition without decreased expression are sufficient to cause abnormal Journal of Cell Science 119 (4) Although Ca 2+ -mediated Ca 2+ signaling was preserved in DD keratinocytes (Fig. 6) , Ca 2+ homeostasis was not completely normal, as evidenced by the abnormally low resting cytosolic Ca 2+ concentrations (Table 2) . Baseline cytosolic Ca 2+ concentrations are maintained by the constant interaction of proteins that control Ca 2+ release or influx with proteins that control Ca 2+ extrusion or reuptake. Loss of one of the reuptake mechanisms, such as the Ca 2+ -sequestering SERCA2, resulting from DD mutations or from acute pharmacologic SERCA2 inactivation (Hu et al., 2000; Jones and Sharpe, 1994) , may be expected to increase cytosolic Ca 2+ levels, as seen in HHD keratinocytes (Behne et al., 2003; Hu et al., 2000) . In fact, DD keratinocytes respond to long-term SERCA2 dysfunction by decreasing resting cytosolic Ca 2+ levels (Table 2 ). These cytosolic Ca 2+ concentrations, although lower than those of most mammalian cells, are comparable to those seen in healthy mouse keratinocytes (Li et al., 1995) ; and we find that these DD keratinocytes appeared to retain comparable proliferative capability even though (or perhaps because) their resting cytosolic Ca 2+ concentrations are abnormally decreased. Decreased baseline cytosolic Ca 2+ levels were unlikely to result from changes in plasma membrane channels or transporters, as Ca 2+ influx and efflux were unchanged in DD compared with normal keratinocytes. However, increased hSPCA1 may contribute to changes in resting cytosolic Ca 2+ , as inactivating ATP2C1 with siRNA, in addition to abrogating the Ca 2+ response, also increased baseline cytosolic Ca 2+ in both normal and DD keratinocytes (compare Table 6 with Table 3) , consistent with changes seen in HHD keratinocytes (Behne et al., 2003; Hu et al., 2000) , in which the ATP2C1 is mutated. According to Liu and co-workers, in cells overexpressing the plasma membrane Ca 2+ -ATPase, PMCA1a, the activity of the Ca 2+ release-activated channels (CRAC) pathway is upregulated, whereas the inositol 1,4,5-trisphosphate receptor (IP3R) and the SERCA pumps are downregulated (Liu et al., 1996) . In Chinese hamster ovary (CHO) cells overexpressing PMCA4, a reduction in SERCA2b expression levels has been described (Guerini et al., 1995) . It is conceivable that a compensatory mechanism relates Ca 2+ efflux by the cell membrane ATPases to the activity of the ER Ca 2+ -ATPases, through the regulation of the respective genes. Our data, however, show that overexpression of PMCA proteins is at best small and non-uniformly observed across the range of DD mutations studied; apart from the ATP2A2 mutations, the DD keratinocyte donors differed regarding age, gender and genetic background. In addition, Ca 2+ efflux was not increased in DD keratinocytes, suggesting that PMCA does not play a significant compensatory role.
Conversely, we have found evidence of several-fold overexpression of hSPCA1 in DD keratinocytes. Moreover, we found that compensatory overexpression of this pump in response to chronic SERCA2 deficiency appears to be essential for a normal Ca 2+ response to raised extracellular Ca 2+ levels and partially compensates for SERCA2 functional deficiency by enabling DD keratinocyte survival. Thus, this report adds to the growing body of information demonstrating that this previously obscure (to mammalian cell biologists) Ca 2+ -ATPase in fact plays an essential role in mammalian cell Ca 2+ signaling. For example, Reinhardt and co-workers observed that overexpression of rat SPCA in COS-7 cells caused significant alterations in several of the cell Ca 2+ transport molecules and dramatically increased the cell division rate (Reinhardt et al., 2004 Taken together, the yeast and human data strongly suggest that SPCA is the mammalian Golgi Ca 2+ -ATPase. The opposing argument put forth by Taylor and co-workers (Taylor et al., 1997) is that the Golgi complex does not contain a unique resident Ca 2+ -ATPase. They state that all Ca 2+ uptake into Golgi can be attributed to PMCAs in transit to the plasma membrane and to SERCAs that are not restricted to the ER. This is at odds with the data from the present study, where we show that specific inhibition of hSPCA1 abolishes Ca 2+ response in DD keratinocytes. A major role for hSPCA1 in keratinocyte Ca 2+ homeostasis is thus warranted. The subcellular specialization of hSPCA1 may underlie the differences in clinical manifestations between DD and HHD. hSPCA1 deficiency causes acantholysis, whereas mutations in the gene encoding SERCA2 cause both acantholysis and apoptosis. In turn, the clinical phenotype of acantholysis plus apoptosis in DD probably reflects the varied functions of the keratinocyte hSPCA1-versus SERCA2-controlled Ca 2+ stores.
Materials and Methods
DD patients and molecular diagnosis
All patients (Table 1) gave informed consent. Biopsies were taken from the unaffected abdominal skin. Control biopsies of normal skin were obtained from two age-matched controls. Patients were screened for mutations in the ATP2A2 gene. PCR amplification of the 21 exons and flanking splice sites of ATP2A2 was performed using previously published primers and protocols (Sakuntabhai et al., 1999) . PCR products were sequenced on an ABI 377 automated sequencer using the BigDye chemistry (Applied Biosystems).
Mutations
The S920Y mutation found in patient DD2 was identified previously and the functional analysis of this mutation has been described (Ahn et al., 2003; . The A998fsX33 mutation found in DD3 occurs in the region specific to the SERCA2b isoform and was identified previously . The N767S missense mutation found in DD5 has been reported previously by others Ruiz-Perez et al., 1999) . The previously unpublished mutations, Y203del (DD1, deletion) and S346F (DD4, missense), affect highly conserved amino acid positions, respectively in the actuator domain of SERCA2 and the phosphorylation domain next to the phosphorylation site (Asp351).
Cell culture
Biopsies were explanted from adult normal skin (surgical skin margins) or clinically normal DD skin (punch biopsies) and primary keratinocytes were isolated and grown as previously described (Rheinwald and Green, 1975) . Second to fifth passage cultured human keratinocytes were grown in 0.06 mM Ca 2+ EpiLife medium (Cascade Biologics, Eugene, Oregon) to approximately 60-80% confluence (Boyce and Ham, 1983) .
Ca 2+ measurements
To study calcium influx (Ca i ), normal and DD keratinocytes were cultured in sixwell plates to 70-80% confluence (Grando et al., 1996) . Cells were washed for 10 minutes in Ca
2+
-free buffer (20 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mg/dl glucose, pH 7.4), then incubated for 1.5 hours at 37°C influx, cells were initially perfused with a solution containing 138 mM NaCl, 2.7 mM KCl, 0.01 M phosphate, 10 mM glucose, 0 mM CaCl 2 plus 0.5 M EGTA, pH 7.4., then perfused with the same solution with the Ca 2+ concentration increased to 0.06 mM, without EGTA. A calibration curve was constructed using a standard calibration kit (Molecular Probes, Eugene, OR). Table 2 relates to cells from all five DD mutants. Tables 3 and 4 contain data from DD1, DD2 and DD3. Because of the technical complexity and numbers of cells needed to perform the 45 Ca 2+ and siRNA experiments, the 45 Ca 2+ experiments were done with cells from DD1 and DD2, whereas the siRNA experiments were done with cells from a single mutant, DD3. DD3 was chosen for siRNA studies because its mutation occurs in the region specific to the SERCA2b isoform, which we previously have shown is sufficient to cause Darier disease . 
SDS-PAGE and immunoblotting
For PMCA and SERCA2 detection, cell lysates in 2ϫ Laemmli SDS sample buffer (2 g total protein per well) were fractionated on 10% polyacrylamide gels and transferred to nitrocellulose membranes. Membranes were blocked in PBS with 5% non-fat dry milk, 1% BSA and 0.5% Tween-20, and incubated at room temperature with the relevant primary antibody for 1 hour: mouse monoclonal anti-human SERCA2 antibody, clone IID8 (Biomol), 1:5000; mouse monoclonal anti-human PMCA, clone 5F10 (Abcam), 1:4000; and rabbit anti-human GAPDH polyclonal antibody (Abcam), 1:20,000. Chemiluminescent detection was performed using secondary reagents from the ECL Plus western blotting detection system (Amersham). The protein contents of the samples were quantified to ensure equal loading of protein into each well. For hSPCA1 detection, cells were lysed in a buffer containing 50 mM Tris-HCl pH 7.4, 150 mM KCl, 250 mM sucrose, with addition of 1 tablet of protease inhibitors per 10 ml of buffer (Complete Mini EDTA-free, Roche Diagnostics) and 30 g total protein per well was fractionated by SDS-PAGE. Following transfer of proteins to PVDF membranes and blocking with 5% milk, 0.5% Tween-20 in PBS, samples were incubated overnight at 4°C with antihuman hSPCA1 primary antibody (Santa Cruz Biotechnology), 1:1000 in the blocking solution. Protein expression also was normalized using an antibody to ␤-actin (Sigma, clone AC-74), 1:5000 dilution. To quantify calcium pump expression in DD keratinocytes, densitometry was performed on the chemiluminescence photo images, using a Bio-Rad GS-710 scanner and Quantity One analysis software. Density values were normalized to loading control expression (GAPDH or ␤-actin) within same samples, and a percentage value for the difference between conditions was calculated.
Small interfering RNA
The effectiveness of potential siRNA candidates was first predicted by choosing a G/C content of approximately 50%, and homology to ATP2C1 or ATP2A2 was checked by running the sequence of the designed siRNA against the full genome sequence in BLAST search (http://www.ncbi.nlm.nih.gov/BLAST/). After testing, one optimum sequence to silence ATP2C1 (codon position: 150, 47% G/C content, 5Ј-agg cuc gcc uau gac uaa cTT-3Ј) and one sequence to silence ATP2A2 (codon position: 2515, 57% G/C content; 5Ј-gcg ccg acg uaa cag cca aTT-3Ј) were selected. The oligoribonucleotides were synthesized by TriLink Biotechnologies (San Diego, CA). At 75% confluence, primary normal and DD keratinocytes were treated with siRNA suspended in 0.03 mM Ca 2+ , serum-free medium using the Trans-Messenger Transfection Kit (Qiagen). Control normal and DD keratinocytes were treated using only the transfection reagents. No signs of cytotoxicity were observed with this protocol in experimental or control keratinocytes. The medium was changed after 4 hours, and cells were harvested after 48 hours (DD keratinocytes) and 72 hours
